Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Neuralstem completes private placement of convertible preferred and common stock

December 14, 2016 10:59 PM UTC

Neuralstem raised $20 million through the sale of 28.5 million shares at $0.25 and 1 million shares of series A convertible preferred stock at $12.79 in a private placement with Tianjin Pharmaceutical...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Seneca Biopharma Inc.